Back to results
US 9,845,349 B2Granted
Regulating Bacillus anthracis lethal factor activity via an activating epitope region
AssigneeThe United States of America, as represented by the Secretary, Department of Health and Human Services
InventorsJason Marc Goldstein, Conrad P. Quinn, Dennis A. Bagarozzi, Jr.
Life of this patent
Estimating the term…
Abstract
Provided are antibodies capable of binding to a particular epitope or specifically binding to LF or LTx and enhancing the activity of the LF or LTx relative to the LF or LTx absent the antibody binding.
Claims5
The monoclonal antibody AVR1674 produced by hybridoma clone LFG2:4B10 that is deposited as PTA-123504.
A hybridoma clone LFG2:4B10 that is deposited under ATCC accession number PTA-123504.
Dependencies are inferred from the claim text.